Rascase Injection
Marketer
Sayre Therapeutics Pvt Ltd
Salt Composition
Rasburicase (1.5mg)
Overview Rascase Injection
Rascase Injection treats elevated uric acid levels resulting from chemotherapy. By reducing blood uric acid, it safeguards against kidney damage in oncology patients. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your physician, depending on your treatment plan and may be adjusted. Adhere strictly to prescribed instructions; incorrect usage or overdosage can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include nausea, headache, vomiting, and rash. However, immediately report breathing difficulties, chest pain, facial or throat swelling, itching, or dizziness. Regular blood uric acid monitoring is standard during treatment. Maintaining adequate hydration is recommended. Inform your doctor of all other medications and pre-existing conditions to ensure safe and effective use, as drug interactions are possible.
Uses of Rascase Injection
Managing hyperuricemia secondary to cytotoxic therapy
Major Benefits of Rascase Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Rascase Injection:
- Nausea
- Headache
- Vomiting
- Rash
- Hives
- Fever
- Diarrhea
How to use Rascase Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Rascase Injection works:
Rascase Injection functions by interacting with an enzyme to convert uric acid into the inert compound allantoin, consequently lowering serum uric acid concentrations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rascase Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Rascase Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Rascase Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability may be affected by Rascase Injection; its impact is currently undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Rascase Injection appears safe for individuals with kidney impairment. Preliminary findings indicate dose modification may not be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Rascase Injection in individuals with liver impairment appears to pose minimal risk. Current evidence indicates dose modification for Rascase Injection may be unnecessary in this population. Physician consultation is advised.
What if you forget to take Rascase Injection :
NA
Facts to Know About Rascase Injection
| Label | Value |
|---|---|
| Chemical Category | Recombinant Xanthine Oxidoreductase |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Chemotherapy with uricolytic agents |
3,018 People bought this recently